2020, Number 2
Next >>
Rev Hematol Mex 2020; 21 (2)
Identifying the precursor of multiple myeloma
Tarín-Arzaga LC
Language: Spanish
References: 10
Page: 73-75
PDF size: 160.46 Kb.
Text Extraction
No abstract.
REFERENCES
Kyle RA, Larson DR, Therneau TM, et al. Long-term followup of monoclonal gammopathy of undetermined significance. N Engl J Med 2018;378(3):241-249. DOI: 10.1056/ NEJMoa1709974.
Kyle RA, Durie BGM, Rajkumar SV, et al. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia 2010;24:1121-1127. doi: 10.1038/ leu.2010.60.
Berenson JR, Anderson KC, Audell RA, et al. Monoclonal gammopathy of undetermined significance: a consensus statement. Br J Haematol 2010;150(1):28-38. doi: 10.1111/j.1365-2141.2010.08207.x.
Therneau TM, Kyle RA, Melton LJ, et al. Incidence of monoclonal gammopathy of undetermined significance and estimation of duration before first clinical recognition. Mayo Clin Proc 2012;87(11):1071-1079. doi: 10.1016/j. mayocp.2012.06.014.
Murray D, Kumar SK, Kyle RA, et al. Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement. Blood Cancer J 2019 Dec 13;9(12):102. doi: 10.1038/s41408-019-0263-z.
Landgren O, Hofmann JN, McShance CM, et al. Association of immune marker changes with progression of monoclonal gammopathy of undetermined significance to multiple myeloma JAMA 2019;5(9):1293-1301. doi: 10.1001/ jamaoncol.2019.1568.
Sigurdardottir EE, Turesson I, Lund SH, et al. The role of diagnosis and clinical follow-up of monoclonal gammopathy of undetermined significance on survival multiple myeloma. JAMA Oncol 2015;1(2):168-174. doi: 10.1001/ jamaoncol.2015.23.
Goyal G, Rajkumar SV, Lacy MQ, et al. Impact of prior diagnosis of monoclonal gammopathy on outcomes in newly diagnosed multiple myeloma. Leukemia 2019;33(5):1273- 1277. doi: 10.1038/s41375-019-0419-7.
Weiss BM, Abadie J, Verma P, et al. A monoclonal gammopathy precedes multiple myeloma in most patients. Blood 2009;113:5418-5422. doi: 10.1182/ blood-2008-12-195008.
Landgren O, Kyle RA, Pfeiffer RM, et al. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood 2009;113:5412-5417. doi: 10.1182/ blood-2008-12-194241.
Full text